Global Vaccine Sales Market is projected to reach a market value of US$453.95 Billion in 2032: Visiongain Research Inc
05 avr. 2022 09h00 HE
|
Visiongain Ltd
Visiongain has launched a new report on Vaccine Sales Market Report Forecast 2022-2032: - Market Segment by Indication (Pneumococcal, Rotavirus, Influenza, Hepatitis, COVID-19, Measles, Mumps &...
Vaccine Adjuvants Market Report Up to 2031: Visiongain Research Inc
29 mars 2022 11h00 HE
|
Visiongain Ltd
Visiongain has published a forecast study of the “Vaccine Adjuvants Market Report 2021-2031”. Forecasts by Type (Pathogen, Adjuvant Emulsion, Particulate, Combination, Others,), Route of...
Bioprocess Validation Market Report Up to 2031: Visiongain Research Inc
09 mars 2022 09h00 HE
|
Visiongain Ltd
Visiongain has published a new report on Bioprocess Validation Market Report : Forecasts by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter...
Biological Imaging Reagents Market Report Up to 2031: Visiongain Research Inc
28 févr. 2022 09h00 HE
|
Visiongain Ltd
Visiongain has published a new report on Biological Imaging Reagents Market Report 2021-2031 Forecasts By Product Type (Contrast Reagents, Nuclear Reagents, Optical Imaging Reagents, Fluorescent Dyes...
Global Decentralized Clinical Trials Market is projected to grow at a CAGR of 6.95% By 2032: Visiongain Research Inc
26 janv. 2022 11h19 HE
|
Visiongain Ltd
Visiongain has published a new report entitled the Decentralized Clinical Trials Market Report 2022-2032. It includes profiles of Decentralized Clinical Trials and Forecasts by Study Design...
Animal Nutrition Ingredients Market Report Up to 2031: Visiongain Research Inc
11 janv. 2022 10h09 HE
|
Visiongain Ltd
Visiongain has published a new report on Animal Nutrition Ingredients Market Report to 2031. The market is segmented on the basis of livestock, nutrients, and by end-user. By livestock, the market is...
Neurological Disorder Drugs Market Report Up to 2031: Visiongain Research Inc
14 déc. 2021 09h19 HE
|
Visiongain Ltd
Visiongain has published a new report on Neurological Disorder Drugs Market Report 2021-2031: Forecasts By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic,...
Neurotrophic Keratitis Market Report Up to 2031: Visiongain Research Inc
13 déc. 2021 09h00 HE
|
Visiongain Ltd
Visiongain has published a new report on Neurotrophic Keratitis Market Report 2021-2031: Forecasts By Treatment (Drugs, Devices, and Surgical Intervention) By Stage (Stage I, Stage II, and Stage III),...
Osteoporosis Drugs Market Report Up to 2031: Visiongain Research Inc
07 déc. 2021 09h30 HE
|
Visiongain Ltd
Visiongain has published a new report on Osteoporosis Drugs Market Report 2021-2031: Forecasts By Type (Primary Osteoporosis, and Secondary Osteoporosis), By Treatment Type (Medication, and Surgery),...
Global Epilepsy Therapeutics Market worth US$16.6 Billion by 2031: Visiongain Research Inc.
26 oct. 2021 11h26 HE
|
Visiongain Ltd
Global Epilepsy Therapeutics Market Report, Forecasts 2021-2031: Market Segment by Drug Class (First Generation, Second Generation and Third Generation Drugs) By Distribution Channel (Hospital...